Aetion

Acquired

Real-World Evidence Solutions | RWE Analytics

New York, United States · Founded 2013 · $203.2M raised

Headquarters
New York, New York
Employees
201–500
Founded
2013
Business Model
B2B
Website
aetion.com
Total Funding
$203.2M
Last Round
$110.0M Series CMay 2021
Rounds
3
Acquired by
DatavantJul 2025

About

Aetion is a healthcare technology company providing decision-grade real-world evidence software to biopharmaceutical manufacturers, payers, and regulatory agencies. Its platform includes Discover, Activate, Substantiate, and Generate products for RWE analysis. Aetion was acquired by Datavant in July 2025.

Summary

Aetion is a Healthcare company based in New York, United States, founded in 2013. It has raised $203.2M in total across 3 rounds, most recently a $110.0M Series C round in May 2021. Investors include Flare Capital Partners, Lakestar and Datavant.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionJul 2025

Sign up to see all 4 rounds

Series A through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aetion on Indexed.vc
<a href="https://indexed.vc/companies/aetion"><img src="https://indexed.vc/api/badge/company/aetion" alt="Aetion on Indexed.vc" width="260" height="76" /></a>